Lee Biosolutions Achieves FDA Registration

St. Louis, Missouri – Lee Biosolutions (www.leebio.com) was recently registered with the United States Food and Drug Administration as a medical materials producer. Registration provides the FDA with the location of medical device manufacturing facilities and importers.

While Lee Bio was not required to register with the FDA by law, President Burton Lee said the company decided to register as a means of keeping up with the requirements and regulations that his customers must comply with.

“Registration helps us keep an eye on the rules that our customers are required to adhere to.” Lee said. “It enables us to establish our business processes in line with our customers’ requirements to better meet their needs.”

Lee Biosolutions customers are research labs across the country that rely on the raw materials that Lee Bio provides in the development of tomorrow’s cures.

Lee Biosolutions is known as a leading manufacturer of renin and myeloperoxidase (MPO). Renin is an enzyme used in the diagnosis and treatment of cardiovascular diseases. MPO is a marker used in the detection of acute myocardial infarction, and the differentiation between myeloid and lymphoid leukemia.

For over 30 years, Lee Biosolutions has been providing proteins, enzymes and other materials to research facilities around the country that work to advance the healthcare industry. By providing Solutions on Demand, Lee Biosolutions has become the preferred source for materials such as renin and myeloperoxidase (MPO).

For more information, please contact Burton Lee at 314-968-1091, or visit Lee Biosolutions online at www.leebio.com.

###